TORONTO (September 2, 2016): Today, the Canadian Medical Cannabis Council (CMCC) announced that the Canadian Epilepsy Alliance (CEA) has joined seven other leading patient groups from across Canada as the newest member of the medical cannabis industry’s first Patient Advisory Committee (PAC). The Committee works to ensure patients and their best interests are the focus of the practices, activities and policy advocacy of CMCC.
CEA joins other PAC members including the Canadian AIDS Society; Arthritis Society of Canada; Canadians for Fair Access to Medical Marijuana (CFAMM); The Wellness Soldier; ILC Foundation; Canadian Cancer Survivor Network and Canadian Hospice Palliative Care Association.
“We are happy to welcome CEA to the CMCC, as we share the same core value of putting patient care first and amplifying the patient’s voice,” says Jonathan Zaid, CMCC PAC Chairman, representing CFAMM.
“CEA has been a long-standing, strong advocate for Canadians with epilepsy,” says Philippe Lucas, CMCC’s Interim Executive Director. “CEA is a welcomed addition to this dynamic group of organizations, whose voices will only become stronger with their presence.”
The Canadian Epilepsy Alliance works to raise awareness and address issues of national importance to people living with epilepsy, share resources and leverage partnerships so quality of life for those living with a seizure disorder will continue to improve.
“CEA was formed to give a stronger voice to Canadians with epilepsy,” says CEA’s Research and Advocacy Representative for Canadian Epilepsy Alliance, Alex Repetski. “I have seen the benefits of medical cannabis in the treatment of epilepsy first hand, and believe it can be of value to many people who are looking for more effective ways to treat seizure disorders. We are pleased to be joining CMCC’s Patient Advisory Committee, and look forward to working with our new partners to strengthen the voice of all advocates who are seeking ways of bringing medical cannabis-related patient care issues to the forefront.“
About the Canadian Epilepsy Alliance (CEA)
The Canadian Epilepsy Alliance (CEA) is a Canada-wide network of grassroots organizations dedicated to the promotion of independence and quality of life for people with epilepsy and their families, through support services, information, advocacy, and public awareness. For more information, please visit www.epilepsymatters.com
About the Canadian Medical Cannabis Council (CMCC)
The Canadian Medical Cannabis Council is an industry group representing stakeholders who are committed to advancing the highest standards of integrity, safety, quality, access, security and research within Canada’s medical cannabis industry. All CMCC members are required to adhere to a Code of Ethics designed to serve patients’ best interests.
For more information, or to speak with a representative of CMCC, please contact:
Kristen Ryan, Director of Public Relations, Tilray